Mr. Chien Huang reports

TITAN ANNOUNCES RESIGNATIONS OF DIRECTORS

Following Titan Medical Inc.'s annual general meeting held on Sept. 30, 2024, and in accordance with Titan's majority voting policy, Anthony Giovinazzo, Cathy Steiner, Cary Vance and Paul Cataford have tendered to the board of directors their resignations as directors of Titan (including Mr. Cataford's resignation as board chairman).

Pursuant to the voting policy, the corporate governance and nominating committee of the corporation must consider such resignations and make a recommendation to the board as to whether to accept such resignations within 90 days of the meeting. In its deliberations, the committee may consider, among other things, the effect any resignation may have on the corporation's ability to comply with any applicable governance rules and policies.

In accordance with Titan's articles and corporate law requirements, Titan must have a minimum of three directors, and under the applicable securities instruments governing audit committees, Titan's audit committee must currently comprise a minimum of three independent directors.

As a result of the foregoing, the board has only accepted Mr. Cataford's and Ms. Vance's resignations with immediate effect at this time.

About Titan Medical Inc.

Titan Medical, a medical technology company incorporated under the Business Corporations Act (Ontario) and headquartered in Toronto, Ont., has developed an expansive patent portfolio related to the enhancement of robotic assisted surgery (RAS), including through a single access point, and is currently focused on evaluating new opportunities to further develop and license its intellectual property.

We seek Safe Harbor.